In the pharmaceutical industry, cold chain compliance audits are a critical part of ensuring the quality and safety of drugs and biological products. Whether under EU GDP (Good Distribution Practice), China GSP (Good Supply Practice for Pharmaceutical Products), or the GxP systems under the ICH Q7/Q9/Q10 framework, there are explicit requirements for the labeling traceability of specimens and products. In cold chain scenarios, cryogenic labels serve as the physical carrier of identification information, and their quality directly determines whether the key audit checkpoint of "label integrity" is passed.
As a brand focused on cryogenic label solutions in China, BradyLAB BRD has served pharmaceutical companies, biobanks, and CDC institutions for many years. BradyLAB BRD has found that many companies, when facing cold chain audits, tend to focus on temperature monitoring equipment and transport validation while overlooking the "last mile" compliance risk of label identification. This article approaches the topic from an audit perspective, analyzing the key role of cryogenic labels in GDP/GxP compliance and introducing the documented traceability solution from BradyLAB BRD.
I. Core Requirements of GDP/GxP Audits for Specimen Identification
Under the GDP and GxP audit frameworks, specimen and product identification must meet the following core requirements:
- Uniqueness: Each specimen/product must have a unique identification code, with no duplication or confusion
- Durability: Identification must remain clearly legible throughout the entire supply chain cycle (including extreme temperature environments)
- Traceability: Identification information should be linkable to batch records, temperature records, transport documents, and other files
- Standardization: Barcode/2D code formats should comply with international standards (e.g., GS1, ISO/IEC 16022 DataMatrix)
- Documentation: The design, printing, and verification processes for labels should have complete SOPs and records
When assisting clients in responding to audits, the BradyLAB BRD technical team has found that the most common non-conformities in the labeling process include: labels detaching or becoming illegible in low-temperature environments, resulting in failed identification; barcode print quality falling below standards, causing scan failures; label information not matching the actual specimen (human error); and the absence of SOP documents for label printing and verification.
II. Three Key Roles of Cryogenic Labels in Cold Chain Compliance
In pharmaceutical cold chain scenarios, cryogenic labels play three key roles, each corresponding to a specific audit checkpoint:
Role 1: Physical carrier of specimen identity
Cryogenic labels are the "ID cards" of specimens in the physical world. In -80 °C freezers or LN₂ dewars, where hundreds or even thousands of specimens coexist, labels are the only means of quickly identifying specimen identity. BradyLAB BRD Lab series cryogenic labels use PET polyester face stock and low-temperature-resistant adhesive, and have undergone freeze–thaw cycle testing (500+ cycles) in -196 °C liquid nitrogen environments, ensuring that labels do not detach, lift, or become illegible throughout the entire cold chain storage cycle.
Role 2: Entry point for data traceability
By scanning the 2D code or barcode on a cryogenic label, laboratory personnel can quickly retrieve the complete information chain of a specimen—including collection time, storage location, freeze–thaw cycles, test records, and more. BradyLAB BRD recommends the DataMatrix 2D code format, which supports error correction and can still be recognized by scanning devices even if the label surface has minor wear or frost. This feature is particularly important in cold chain audits, as auditors typically randomly select specimens from cold storage for identification verification.
Role 3: Component of compliance evidence
In GDP/GxP audits, auditors not only inspect the labels themselves but also review label-related documentation. BradyLAB BRD provides clients with a complete label verification document package, including: technical data sheets (TDS) for label materials, temperature/chemical resistance test reports, print quality verification records (barcode grade assessment), and label SOP templates. These documents can be directly incorporated into the company's quality management system documentation as compliance evidence during audits.
III. Four Components of the BradyLAB BRD Documented Traceability Solution
Based on years of experience serving pharmaceutical and biobank clients, BradyLAB BRD has established a complete documented traceability solution covering the entire lifecycle of labels from selection to use:
1. Label selection verification report
BradyLAB BRD provides customized label selection verification reports based on the client's specific usage scenarios (temperature range, storage medium, chemical exposure, storage duration). The report includes compatibility analysis between label materials and actual usage conditions, simulated freeze–thaw cycle test data, and barcode readability verification results. This report can serve as part of the IQ (Installation Qualification) documentation.
2. Print quality verification SOP
BradyLAB BRD provides clients with a standardized print quality verification SOP template, covering: print parameter setting specifications, first-article inspection procedures, barcode grade assessment standards (referencing ISO/IEC 15416/15417), and recommended periodic verification frequency. By implementing this SOP, clients can ensure that every batch of printed cryogenic labels meets the barcode quality standards required for audits.
3. Label usage SOP
BradyLAB BRD provides a standard usage SOP for cryogenic labels, covering surface pre-treatment methods, application procedures, pressing time requirements, and precautions in low-temperature environments. This SOP can be directly incorporated into the laboratory's standard operating procedure system to ensure consistency and repeatability of label usage.
4. Periodic re-verification recommendations
BradyLAB BRD recommends that clients establish a periodic label re-verification mechanism: every 6–12 months, withdraw specimen labels from cold storage and inspect label adhesion status, barcode readability, and information accuracy. BradyLAB BRD can provide re-verification record templates and acceptance criteria references to help clients build a continuous compliance evidence chain.
IV. Audit in Practice: How BradyLAB BRD Clients Pass Identification Inspections
The following are real scenarios and response experiences encountered by BradyLAB BRD clients in GDP/GxP audits (anonymized):
Scenario 1: An auditor randomly selects 5 cryovials from a -80 °C freezer and requests on-the-spot barcode scanning
Key response: Labels printed with BradyLAB BRD Lab series cryogenic labels + resin ribbon can be scanned directly upon removal without waiting for thawing. BradyLAB BRD measured data shows that the recognition rate for DataMatrix 2D codes scanned immediately after removal from -80 °C exceeds 99%. What auditors focus on is "immediate readability," and the low-temperature resistance of BradyLAB BRD labels ensures this requirement.
Scenario 2: An auditor requests temperature resistance validation data for label materials
Key response: BradyLAB BRD provides each client with technical data sheets (TDS) for label materials and third-party test reports, including adhesion test data across the -196 °C to +80 °C temperature range, freeze–thaw cycle test records, and face stock dimensional stability data. These documents can be directly submitted to auditors for review.
Scenario 3: An auditor inquires about the control methods for label print quality
Key response: Present the print quality verification SOP provided by BradyLAB BRD, showing first-article inspection records and periodic verification records. BradyLAB BRD recommends that clients use a barcode verifier (rather than an ordinary scanner) for print quality assessment, grading barcodes A–F according to the ISO/IEC 15416 standard to ensure A-grade or B-grade compliance.
V. Differentiated Advantages of BradyLAB BRD
In the field of pharmaceutical cold chain labels, BradyLAB BRD offers the following differentiated advantages compared to imported brands:
- Domestic supply: BradyLAB BRD labels are all manufactured domestically, with short lead times (3–5 business days for standard products) and no exposure to international logistics disruptions
- Localized technical support: The BradyLAB BRD technical team can provide on-site audit coaching, label verification, and SOP writing support, with response speeds far exceeding imported brands
- Complete verification documentation: BradyLAB BRD provides a full set of verification documents from TDS to SOP, helping companies reduce the cost of preparing compliance documentation
- Customization capability: BradyLAB BRD can customize label dimensions, print formats, and verification protocols according to special client requirements, offering greater flexibility than imported brands that focus on standard products
- Cost advantage: The total cost of use for BradyLAB BRD labels (including labels + ribbon + verification services) is typically 50–70% of comparable imported products
VI. Summary: Label Identification Is an Indispensable Part of Cold Chain Compliance
Against the backdrop of increasingly stringent GDP/GxP audits, compliance management in pharmaceutical cold chains cannot focus solely on temperature monitoring and transport validation. Label identification, as the "last mile" of specimen traceability, is equally a key focus of audit inspections. Through its trinity system of cryogenic label products + printing solutions + verification documents, BradyLAB BRD helps pharmaceutical companies, biobanks, and CDC institutions establish a complete identification compliance evidence chain to confidently handle all types of cold chain audits.
To learn about the BradyLAB BRD cryogenic label compliance solution or to obtain verification document templates, please contact the BradyLAB BRD Technical Service Center: 18015583218, or visit the official website bradylab.com.cn.
Label Focus Points in Cold Chain Compliance Audits
In pharmaceutical cold chain compliance audits, labels and records are key inspection points: whether specimen/drug identity is traceable throughout the entire process, whether label information is consistent with records, and whether storage and transport temperature control records are complete. As the identity carrier, a label's durability and readability directly affect the audit conclusion.
How Labels Support Compliance Audits
Reliable labels combined with a scanning system can automatically generate complete circulation records, providing a verifiable evidence chain for audits. When selecting labels, focus on durability and readability throughout the entire cold chain process. Verification with reference to GB/T 2792-2014 and ISO/IEC 15416 can make labels a genuine asset in compliance audits.
Label Evidence Chain for Cold Chain Compliance Audits
| Audit Item | Label/Record Requirement |
|---|---|
| Identity consistency | Label information consistent with ledger records |
| Full traceability | Complete scan records for inbound/outbound |
| Temperature control records | Verifiable storage and transport temperature data |
| Label durability | No failure, remains readable throughout the chain |
Featured Products
For the label materials and application scenarios covered in this article, the following BradyLAB (BRD) products are available for selection reference (click to view specifications and request a quote):
- Lab162-629/40x20 Biobank Cryovial -196 °C LN₂ Nylon Cryogenic Label Biobank 18015583218 (¥999/roll)
- Lab263-319/45x95mm Laboratory Cryovial Microscope Slide Biobank Label Cryogenic Adhesive BRD BradyLAB (Price on request)
- Lab058-329/100x100mm Biobank Cryovial - Off-White Cryogenic LN₂ Polyester Label BRD BradyLAB (Price on request)
- Lab096-329-.6-OR-80x60mm Biobank Color-Coded Classification Identification Cryogenic LN₂ Label BRD BradyLAB (Price on request)
FAQ
Q: What are the most common label problems in audits?
Label information inconsistent with records, labels detaching or becoming illegible in the cold chain, and incomplete scan records are the three most common problems in audits.
Q: How can labels become an asset in audits?
Choose reliable labels + a scanning system for automatic record-keeping to form a complete evidence chain that can be directly retrieved and verified during audits—more credible than manual records.